Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Are Publicly Funded Health Databases Geographically Detailed and Timely Enough to Support Patient-Centered Outcomes Research?

Min S, Martin LT, Rutter CM, Concannon TW.

J Gen Intern Med. 2018 Sep 20. doi: 10.1007/s11606-018-4673-6. [Epub ahead of print]

PMID:
30511288
2.

Characteristics of Chiropractic Patients Being Treated for Chronic Low Back and Neck Pain.

Herman PM, Kommareddi M, Sorbero ME, Rutter CM, Hays RD, Hilton LG, Ryan GW, Coulter ID.

J Manipulative Physiol Ther. 2018 Jul - Aug;41(6):445-455. doi: 10.1016/j.jmpt.2018.02.001. Epub 2018 Aug 16.

PMID:
30121129
3.

Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study.

Rutter CM, Kim JJ, Meester RGS, Sprague BL, Burger EA, Zauber AG, Ergun MA, Campos NG, Doubeni CA, Trentham-Dietz A, Sy S, Alagoz O, Stout N, Lansdorp-Vogelaar I, Corley DA, Tosteson ANA.

Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):158-164. doi: 10.1158/1055-9965.EPI-17-0378. Epub 2017 Nov 17.

PMID:
29150480
4.

Accounting for misclassification in electronic health records-derived exposures using generalized linear finite mixture models.

Hubbard RA, Johnson E, Chubak J, Wernli KJ, Kamineni A, Bogart A, Rutter CM.

Health Serv Outcomes Res Methodol. 2017 Jun;17(2):101-112. doi: 10.1007/s10742-016-0149-5. Epub 2016 Jun 3.

5.

Building capacity for continuous quality improvement (CQI): A pilot study.

Hunter SB, Rutter CM, Ober AJ, Booth MS.

J Subst Abuse Treat. 2017 Oct;81:44-52. doi: 10.1016/j.jsat.2017.07.014. Epub 2017 Aug 2.

6.

Time to Diagnostic Testing After a Positive Colorectal Cancer Screening Test-Reply.

Rutter CM, Inadomi JM.

JAMA. 2017 Aug 1;318(5):483-484. doi: 10.1001/jama.2017.9316. No abstract available.

PMID:
28763547
7.

Cohort restriction based on prior enrollment: Examining potential biases in estimating cancer and mortality risk.

Shortreed SM, Johnson E, Rutter CM, Kamineni A, Wernli KJ, Chubak J.

Obs Stud. 2016 Aug;2:51-64. Epub 2016 Sep 26.

8.

Follow-up of Positive Fecal Test Results: Sooner Is Better, but How Much Better?

Rutter CM, Inadomi JM.

JAMA. 2017 Apr 25;317(16):1627-1628. doi: 10.1001/jama.2017.3629. No abstract available.

PMID:
28444260
9.

Resources and Capabilities of the Department of Veterans Affairs to Provide Timely and Accessible Care to Veterans.

Hussey PS, Ringel JS, Ahluwalia S, Price RA, Buttorff C, Concannon TW, Lovejoy SL, Martsolf GR, Rudin RS, Schultz D, Sloss EM, Watkins KE, Waxman D, Bauman M, Briscombe B, Broyles JR, Burns RM, Chen EK, DeSantis AS, Ecola L, Fischer SH, Friedberg MW, Gidengil CA, Ginsburg PB, Gulden T, Gutierrez CI, Hirshman S, Huang CY, Kandrack R, Kress A, Leuschner KJ, MacCarthy S, Maksabedian EJ, Mann S, Matthews LJ, May LW, Mishra N, Miyashiro L, Muchow AN, Nelson J, Naranjo D, O'Hanlon CE, Pillemer F, Predmore Z, Ross R, Ruder T, Rutter CM, Uscher-Pines L, Vaiana ME, Vesely JV, Hosek SD, Farmer CM.

Rand Health Q. 2016 May 9;5(4):14. eCollection 2016 May 9.

10.

Current and Projected Characteristics and Unique Health Care Needs of the Patient Population Served by the Department of Veterans Affairs.

Eibner C, Krull H, Brown KM, Cefalu M, Mulcahy AW, Pollard M, Shetty K, Adamson DM, Amaral EF, Armour P, Beleche T, Bogdan O, Hastings J, Kapinos K, Kress A, Mendelsohn J, Ross R, Rutter CM, Weinick RM, Woods D, Hosek SD, Farmer CM.

Rand Health Q. 2016 May 9;5(4):13. eCollection 2016 May 9.

11.

Discussion of "A risk-based measure of time-varying prognostic discrimination for survival models," by C. Jason Liang and Patrick J. Heagerty.

Parast L, Rutter CM.

Biometrics. 2017 Sep;73(3):742-744. doi: 10.1111/biom.12630. Epub 2016 Dec 8. No abstract available.

PMID:
27933633
12.

Reply.

Wernli KJ, Brenner AT, Rutter CM, Inadomi JM.

Gastroenterology. 2016 Sep;151(3):564. doi: 10.1053/j.gastro.2016.07.041. Epub 2016 Aug 3. No abstract available.

PMID:
27496674
13.

A restricted look at CRC screening: not considering annual stool testing as an option.

Kuntz KM, Zauber AG, Knudsen AB, Rutter CM, Lansdorp-Vogelaar I, Berger BM, Levin B.

Am J Manag Care. 2016 Jul 1;22(7):e270-4. No abstract available.

14.

Influence of Age and Comorbidity on Colorectal Cancer Screening in the Elderly.

Klabunde CN, Zheng Y, Quinn VP, Beaber EF, Rutter CM, Halm EA, Chubak J, Doubeni CA, Haas JS, Kamineni A, Schapira MM, Vacek PM, Garcia MP, Corley DA; PROSPR consortium.

Am J Prev Med. 2016 Sep;51(3):e67-75. doi: 10.1016/j.amepre.2016.04.018. Epub 2016 Jun 22.

15.

Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force.

Knudsen AB, Zauber AG, Rutter CM, Naber SK, Doria-Rose VP, Pabiniak C, Johanson C, Fischer SE, Lansdorp-Vogelaar I, Kuntz KM.

JAMA. 2016 Jun 21;315(23):2595-609. doi: 10.1001/jama.2016.6828.

16.

Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

Lin JS, Piper MA, Perdue LA, Rutter CM, Webber EM, O'Connor E, Smith N, Whitlock EP.

JAMA. 2016 Jun 21;315(23):2576-94. doi: 10.1001/jama.2016.3332. Review. Erratum in: JAMA. 2016 Aug 2;316(5):545. Erratum in: JAMA. 2016 Oct 4;316(13):1412.

PMID:
27305422
17.

Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.

Halm EA, Beaber EF, McLerran D, Chubak J, Corley DA, Rutter CM, Doubeni CA, Haas JS, Balasubramanian BA.

J Gen Intern Med. 2016 Oct;31(10):1190-7. doi: 10.1007/s11606-016-3760-9. Epub 2016 Jun 8.

18.

Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/Ethnicity.

McCarthy AM, Kim JJ, Beaber EF, Zheng Y, Burnett-Hartman A, Chubak J, Ghai NR, McLerran D, Breen N, Conant EF, Geller BM, Green BB, Klabunde CN, Inrig S, Skinner CS, Quinn VP, Haas JS, Schnall M, Rutter CM, Barlow WE, Corley DA, Armstrong K, Doubeni CA; PROSPR consortium.

Am J Prev Med. 2016 Oct;51(4):507-12. doi: 10.1016/j.amepre.2016.03.017. Epub 2016 Apr 28.

19.

Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems.

Chubak J, Garcia MP, Burnett-Hartman AN, Zheng Y, Corley DA, Halm EA, Singal AG, Klabunde CN, Doubeni CA, Kamineni A, Levin TR, Schottinger JE, Green BB, Quinn VP, Rutter CM; PROSPR consortium.

Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):344-50. doi: 10.1158/1055-9965.EPI-15-0470.

20.

Validation of Models Used to Inform Colorectal Cancer Screening Guidelines: Accuracy and Implications.

Rutter CM, Knudsen AB, Marsh TL, Doria-Rose VP, Johnson E, Pabiniak C, Kuntz KM, van Ballegooijen M, Zauber AG, Lansdorp-Vogelaar I.

Med Decis Making. 2016 Jul;36(5):604-14. doi: 10.1177/0272989X15622642. Epub 2016 Jan 8.

21.

Risks Associated With Anesthesia Services During Colonoscopy.

Wernli KJ, Brenner AT, Rutter CM, Inadomi JM.

Gastroenterology. 2016 Apr;150(4):888-94; quiz e18. doi: 10.1053/j.gastro.2015.12.018. Epub 2015 Dec 18.

22.

Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.

Tosteson AN, Beaber EF, Tiro J, Kim J, McCarthy AM, Quinn VP, Doria-Rose VP, Wheeler CM, Barlow WE, Bronson M, Garcia M, Corley DA, Haas JS, Halm EA, Kamineni A, Rutter CM, Tosteson TD, Trentham-Dietz A, Weaver DL; PROSPR consortium.

J Gen Intern Med. 2016 Apr;31(4):372-9. doi: 10.1007/s11606-015-3552-7.

23.

Cancer Models and Real-world Data: Better Together.

Kim JJ, Tosteson AN, Zauber AG, Sprague BL, Stout NK, Alagoz O, Trentham-Dietz A, Armstrong K, Pruitt SL, Rutter CM; Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) consortium.

J Natl Cancer Inst. 2015 Nov 3;108(2). pii: djv316. doi: 10.1093/jnci/djv316. Print 2016 Feb.

24.

Development of an Algorithm to Classify Colonoscopy Indication from Coded Health Care Data.

Adams KF, Johnson EA, Chubak J, Kamineni A, Doubeni CA, Buist DS, Williams AE, Weinmann S, Doria-Rose VP, Rutter CM.

EGEMS (Wash DC). 2015 May 18;3(1):1171. doi: 10.13063/2327-9214.1171. eCollection 2015.

25.

Misclassification of Breast Imaging Reporting and Data System (BI-RADS) Mammographic Density and Implications for Breast Density Reporting Legislation.

Gard CC, Aiello Bowles EJ, Miglioretti DL, Taplin SH, Rutter CM.

Breast J. 2015 Sep-Oct;21(5):481-9. doi: 10.1111/tbj.12443. Epub 2015 Jul 1.

26.

Do depressed newly diagnosed cancer patients differentially benefit from nurse navigation?

Ludman EJ, McCorkle R, Bowles EA, Rutter CM, Chubak J, Tuzzio L, Jones S, Reid RJ, Penfold R, Wagner EH.

Gen Hosp Psychiatry. 2015 May-Jun;37(3):236-9. doi: 10.1016/j.genhosppsych.2015.02.008. Epub 2015 Feb 28.

27.

Cost-Effectiveness of CT Colonography to Screen for Colorectal Cancer [Internet].

Zauber AG, Knudsen AB, Rutter CM, Lansdorp-Vogelaar I, Savarino JE, van Ballegooijen M, Kuntz KM.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2009 Jan 22.

28.

Estimating screening test utilization using electronic health records data.

Hubbard R, Chubak J, Rutter C.

EGEMS (Wash DC). 2014 Nov 4;2(1):14.

29.

Blood lipids and colorectal polyps: testing an etiologic hypothesis using phenotypic measurements and Mendelian randomization.

Passarelli MN, Newcomb PA, Makar KW, Burnett-Hartman AN, Potter JD, Upton MP, Zhu LC, Rosenfeld ME, Schwartz SM, Rutter CM.

Cancer Causes Control. 2015 Mar;26(3):467-73. doi: 10.1007/s10552-015-0526-3. Epub 2015 Jan 25.

30.

Importance of determining indication for colonoscopy: implications for practice and policy original.

Singal AG, Gupta S, Lee J, Halm EA, Rutter CM, Corley D, Inadomi J.

Clin Gastroenterol Hepatol. 2014 Dec;12(12):1958-63.e1-3. Review. No abstract available.

31.

Prevalence of colonoscopy before age 50.

Rutter CM, Greenlee RT, Johnson E, Stark A, Weinmann S, Kamineni A, Adams K, Doubeni CA.

Prev Med. 2015 Mar;72:126-9. doi: 10.1016/j.ypmed.2014.12.028. Epub 2015 Jan 4.

32.

Assessing the effectiveness of a cancer screening test in the presence of another screening modality.

Chubak J, Hubbard RA, Johnson E, Kamineni A, Rutter CM.

J Med Screen. 2015 Jun;22(2):69-75. doi: 10.1177/0969141314562036. Epub 2014 Dec 9.

33.

Changes in office visit use associated with electronic messaging and telephone encounters among patients with diabetes in the PCMH.

Liss DT, Reid RJ, Grembowski D, Rutter CM, Ross TR, Fishman PA.

Ann Fam Med. 2014 Jul;12(4):338-43. doi: 10.1370/afm.1642.

34.

Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits.

Lansdorp-Vogelaar I, Gulati R, Mariotto AB, Schechter CB, de Carvalho TM, Knudsen AB, van Ravesteyn NT, Heijnsdijk EA, Pabiniak C, van Ballegooijen M, Rutter CM, Kuntz KM, Feuer EJ, Etzioni R, de Koning HJ, Zauber AG, Mandelblatt JS.

Ann Intern Med. 2014 Jul 15;161(2):104-12. doi: 10.7326/M13-2867.

35.

The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium.

Tiro JA, Kamineni A, Levin TR, Zheng Y, Schottinger JS, Rutter CM, Corley DA, Skinner CS, Chubak J, Doubeni CA, Halm EA, Gupta S, Wernli KJ, Klabunde C.

Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1147-58. doi: 10.1158/1055-9965.EPI-13-1217. Epub 2014 Jun 10.

36.

Patterns of colorectal cancer screening uptake in newly eligible men and women.

Wernli KJ, Hubbard RA, Johnson E, Chubak J, Kamineni A, Green BB, Rutter CM.

Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1230-7. doi: 10.1158/1055-9965.EPI-13-1360. Epub 2014 May 3.

37.

Specialty use among patients with treated hypertension in a patient-centered medical home.

Liss DT, Fishman PA, Rutter CM, Grembowski D, Ross TR, Reid RJ.

J Gen Intern Med. 2014 May;29(5):732-40. doi: 10.1007/s11606-014-2776-2.

38.

Perspectives of cancer survivors on the role of different healthcare providers in an integrated delivery system.

Chubak J, Aiello Bowles EJ, Tuzzio L, Ludman E, Rutter CM, Reid RJ, Wagner EH.

J Cancer Surviv. 2014 Jun;8(2):229-38. doi: 10.1007/s11764-013-0335-1. Epub 2013 Dec 19.

39.

Outcomes among chronically ill adults in a medical home prototype.

Liss DT, Fishman PA, Rutter CM, Grembowski D, Ross TR, Johnson EA, Reid RJ.

Am J Manag Care. 2013 Oct 1;19(10):e348-58.

40.

Nurse navigators in early cancer care: a randomized, controlled trial.

Wagner EH, Ludman EJ, Aiello Bowles EJ, Penfold R, Reid RJ, Rutter CM, Chubak J, McCorkle R.

J Clin Oncol. 2014 Jan 1;32(1):12-8. doi: 10.1200/JCO.2013.51.7359. Epub 2013 Nov 25.

41.

Secular trends in colon and rectal cancer relative survival.

Rutter CM, Johnson EA, Feuer EJ, Knudsen AB, Kuntz KM, Schrag D.

J Natl Cancer Inst. 2013 Dec 4;105(23):1806-13. doi: 10.1093/jnci/djt299. Epub 2013 Oct 30.

42.

Does response on the PHQ-9 Depression Questionnaire predict subsequent suicide attempt or suicide death?

Simon GE, Rutter CM, Peterson D, Oliver M, Whiteside U, Operskalski B, Ludman EJ.

Psychiatr Serv. 2013 Dec 1;64(12):1195-202. doi: 10.1176/appi.ps.201200587.

43.

The cumulative risk of false-positive fecal occult blood test after 10 years of colorectal cancer screening.

Hubbard RA, Johnson E, Hsia R, Rutter CM.

Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1612-9. doi: 10.1158/1055-9965.EPI-13-0254. Epub 2013 Jul 18.

44.

Measurement in comparative effectiveness research.

Chubak J, Rutter CM, Kamineni A, Johnson EA, Stout NK, Weiss NS, Doria-Rose VP, Doubeni CA, Buist DS.

Am J Prev Med. 2013 May;44(5):513-9. doi: 10.1016/j.amepre.2013.01.006.

45.

Assessing the accuracy of profiling methods for identifying top providers: performance of mental health care providers.

Ding VY, Hubbard RA, Rutter CM, Simon GE.

Health Serv Outcomes Res Methodol. 2013 Mar 1;13(1):1-17. Epub 2012 Sep 18.

46.

Suspected extracolonic neoplasms detected on CT colonography: literature review and possible outcomes.

Wernli KJ, Rutter CM, Dachman AH, Zafar HM.

Acad Radiol. 2013 Jun;20(6):667-74. doi: 10.1016/j.acra.2013.01.017. Epub 2013 Mar 1. Review.

47.

Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study.

Doubeni CA, Weinmann S, Adams K, Kamineni A, Buist DS, Ash AS, Rutter CM, Doria-Rose VP, Corley DA, Greenlee RT, Chubak J, Williams A, Kroll-Desrosiers AR, Johnson E, Webster J, Richert-Boe K, Levin TR, Fletcher RH, Weiss NS.

Ann Intern Med. 2013 Mar 5;158(5 Pt 1):312-20. doi: 10.7326/0003-4819-158-5-201303050-00003.

48.

Response to past depression treatments is not accurately recalled: comparison of structured recall and patient health questionnaire scores in medical records.

Simon GE, Rutter CM, Stewart C, Pabiniak C, Wehnes L.

J Clin Psychiatry. 2012 Dec;73(12):1503-8. doi: 10.4088/JCP.12m07883.

49.

Patient-rated alliance as a measure of therapist performance in two clinical settings.

Imel ZE, Hubbard RA, Rutter CM, Simon G.

J Consult Clin Psychol. 2013 Feb;81(1):154-65. doi: 10.1037/a0030903. Epub 2012 Dec 10.

PMID:
23231576
50.

Estimated mean sojourn time associated with hemoccult SENSA for detection of proximal and distal colorectal cancer.

Zheng W, Rutter CM.

Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1722-30. doi: 10.1158/1055-9965.EPI-12-0561. Epub 2012 Aug 21.

Supplemental Content

Loading ...
Support Center